Teva Pharmaceutical Industries Ltd (TEVA) 53.57

New Post Public Reply Private Reply Replies (0) Message Board

Aug 3, 2016 at 5:04 PM

Teva Pharmaceutical Industries Ltd (TEVA) 53.57 $TEVA

Dr. Reddy's Completes Acquisition of Product Portfolio from TEVA
BusinessWire - Wed Aug 03, 12:58PM CDT
Dr. Reddy's Laboratories Ltd. (BSE: 500124) (NSE: DRREDDY) (NYSE: RDY) today announced that it successfully completed the previously announced acquisition of eight Abbreviated New Drug Applications (ANDAs) in the U.S. from Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) (TASE: TEVA) and an affiliate of Allergan plc (NYSE: AGN). The acquired portfolio consists of products that are being divested by Teva as a precondition to its closing of the acquisition of Allergan's generics business.
AGN: 252.53 (+1.78), TEVA: 53.57 (+0.61), RDY: 43.86 (-0.24)

5 Drug Stocks to Watch for Earnings on Aug 4: BMRN & More
Zacks Equity Research - Zacks Investment Research - Wed Aug 03, 8:36AM CDT
How will drug stocks like BMRN, TEVA, REGN and others, scheduled to report on Aug 4, fare this earnings season?
ACAD: 37.17 (+0.58), BMRN: 101.46 (+2.39), ALNY: 71.36 (+0.80), TEVA: 53.57 (+0.61), REGN: 441.37 (+6.47)

Teva Announces Acquisition of Anda Inc.
BusinessWire - Wed Aug 03, 6:00AM CDT
Teva Pharmaceutical Industries Ltd., (NYSE and TASE: TEVA) today announced that it has entered into a definitive agreement to purchase Allergan's Anda Inc., the 4th largest distributor of generic pharmaceuticals in the U.S. for $500 million.
TEVA: 53.57 (+0.61)

Allergan Announces Sale of Anda Distribution Business to Teva Pharmaceuticals
PR Newswire - Wed Aug 03, 6:00AM CDT
Allergan plc (NYSE: AGN), a global pharmaceutical company, today announced that it has entered into a definitive agreement under which Teva Pharmaceutical Industries Ltd. will acquire Allergan's Anda, Inc. distribution business for $500 million.
AGN: 252.53 (+1.78), TEVA: 53.57 (+0.61)

Teva Completes Acquisition of Actavis Generics
PR Newswire Europe - Tue Aug 02, 1:08PM CDT
CASTLEFORD, England, August 2, 2016 /PRNewswire/ --
AGN: 252.53 (+1.78), TEVA: 53.57 (+0.61)

Allergan plc Completes Divestiture of Global Generics Business to Teva Pharmaceuticals
PR Newswire - Tue Aug 02, 11:41AM CDT
Allergan plc (NYSE: AGN) today announced that it has completed the divestiture of its global generic pharmaceuticals business to Teva Pharmaceutical Industries Ltd. Allergan has received $33.4 billion in cash and 100.3 million shares of Teva stock valued at $5.4 billion based on the opening price of $53.39 for Teva Pharmaceutical Industries Ltd. shares on August 2, 2016. These shares are subject to a twelve month holding period post-close of the transaction.
AGN: 252.53 (+1.78), TEVA: 53.57 (+0.61)

CORRECTING and REPLACING Teva Pharmaceuticals Initiates Voluntary Nationwide Recall of Seven Lots of Amikacin Sulfate Injection USP 500mg/2 mL (250 mg/mL) and 1 gram/4 mL (250 mg/mL) Vials Due to Potential of Glass Particulate Matter
BusinessWire - Tue Aug 02, 10:10AM CDT
Please replace the release dated July 29, 2016 with the following corrected version due to changes in the paragraph immediately following the table listing the recalled lots.
TEVA: 53.57 (+0.61)

Teva (TEVA): Stock Likely to Beat on Earnings in Q2 Again?
Arpita Dutt - Zacks Investment Research - Tue Aug 02, 6:06AM CDT
Our proven model shows that Teva (TEVA) is likely to beat earnings this quarter because it has the right combination of two key ingredients.
AGN: 252.53 (+1.78), RPTP: 6.17 (+0.23), TECH: 112.65 (-0.05), TEVA: 53.57 (+0.61)

SmarTrend Watching for Potential Rebound in Shares of Teva Pharmaceutical Industries After 1.93% Loss
Comtex SmarTrend(R) - Fri Jul 29, 1:35PM CDT
Teva Pharmaceutical Industries (NASDAQ:TEVA) traded in a range yesterday that spanned from a low of $53.61 to a high of $54.83. Yesterday, the shares fell 1.9%, which took the trading range below the 3-day low of $54.03 on volume of 1.8 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
TEVA: 53.57 (+0.61)

Watch for Teva Pharmaceutical Industries to Potentially Rebound After Falling 1.93% Yesterday
Comtex SmarTrend(R) - Fri Jul 29, 1:34PM CDT
Teva Pharmaceutical Industries (NASDAQ:TEVA) traded in a range yesterday that spanned from a low of $53.61 to a high of $54.83. Yesterday, the shares fell 1.9%, which took the trading range below the 3-day low of $54.03 on volume of 1.8 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
TEVA: 53.57 (+0.61)

Teva Pharmaceuticals Initiates Voluntary Nationwide Recall of Seven Lots of Amikacin Sulfate Injection USP 500mg/2 mL (250 mg/mL) and 1 gram/4 mL (250 mg/mL) Vials Due to Potential of Glass Particulate Matter
BusinessWire - Fri Jul 29, 8:00AM CDT
Teva Pharmaceuticals today announced a voluntary recall of seven lots of Amikacin Sulfate Injection USP, 500 mg/2mL (250 mg/mL) and 1 gram/4mL (250 mg/mL) vials due to the potential for the presence of glass particulate matter. The recalled lots are:
TEVA: 53.57 (+0.61)

InvestorsObserver releases covered-call reports for Valeant Pharmaceuticals, Potash Corporation of Saskatchewan, Barrick Gold Corporation, Teva and Monsanto Company
PR Newswire - Thu Jul 28, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for ABX, MON, POT, TEVA, and VRX.
VRX: 22.36 (+1.19), MON: 104.36 (-1.26), ABX: 22.42 (-0.27), POT: 15.81 (-0.04), TEVA: 53.57 (+0.61)

Teva expect to close $40.5B Allergan generic deal next week
AP - Wed Jul 27, 3:31PM CDT
NEW YORK (AP) — Israeli drugmaker Teva, the largest generic drug company in the world, said Wednesday it expects to complete its $40.5 billion purchase of the generic drug business of competitor Allergan next week after federal regulators approved the deal.
AGN: 252.53 (+1.78), TEVA: 53.57 (+0.61)

Teva to Report Second Quarter 2016 Financial Results on August 4, 2016
BusinessWire - Wed Jul 27, 3:01PM CDT
Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) announced today that it will release its second quarter 2016 financial results on Thursday, August 4, 2016 at 7:00 a.m. ET.
TEVA: 53.57 (+0.61)

Teva Receives Clearance from the U.S. Federal Trade Commission for Actavis Generics Acquisition
BusinessWire - Wed Jul 27, 1:36PM CDT
--Added Capabilities, Assets and Talent Advance Teva's Focus on Patient Needs and Providing Affordable Generic Products to Patients at Every Stage of Life Worldwide
AGN: 252.53 (+1.78), TEVA: 53.57 (+0.61)

Teva Announces Pricing of $15 Billion of Senior Notes in Connection with Pending Acquisition of Actavis Generics
BusinessWire - Mon Jul 18, 8:17PM CDT
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that it successfully priced a debt offering by its special purpose finance subsidiary Teva Pharmaceutical Finance Netherlands III B.V., consisting of the following tranches:
TEVA: 53.57 (+0.61)

Company News for July 14, 2016
Zacks Equity Research - Zacks Investment Research - Thu Jul 14, 9:10AM CDT
Companies In The News are: VRX,TEVA,NOK,HCSG
VRX: 22.36 (+1.19), TEVA: 53.57 (+0.61), HCSG: 38.66 (+0.10), NOK: 5.69 (+0.08)

Teva (TEVA) Provides 2016-2019 Outlook, Shares Gain
Arpita Dutt - Zacks Investment Research - Thu Jul 14, 7:10AM CDT
Teva (TEVA) provided its preliminary outlook for 2016-2019 and expects the Actavis Generics acquisition to go through anytime soon.
AGN: 252.53 (+1.78), MYL: 48.41 (+1.88), TEVA: 53.57 (+0.61), RDY: 43.86 (-0.24)

Michaels and Hess slide, Teva and JetBlue trade higher
AP - Wed Jul 13, 3:27PM CDT
NEW YORK (AP) — Stocks that moved substantially or traded heavily on Wednesday:
AGN: 252.53 (+1.78), HES: 53.39 (+1.64), JUNO: 31.31 (+0.63), TEVA: 53.57 (+0.61), JBLU: 16.90 (-0.11), AET: 116.86 (+1.15), AIR: 23.99 (+0.39)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Choate's: 68 Years of Community and Family Values

Beyond Business: A Legacy of Giving Step into the world of Choate's, a renowned name in the Memphis area not just for its services in air conditioning, heating, plumbing, and electrical needs, but for its unwavering dedication to community service. For 68 years, this family-owned business has made its mark on the heart of Tennessee, spanning three generations and staying...

Elevest Unveils MADE: Shaping Wealth for Athletes, Artists

Turning Talent Into Tangible Wealth Ask any musician or athlete, and they'll tell you—riding those career highs is exhilarating, but financial stability can be a different ballgame. Here comes Elevest Capital with a fresh move meant to set the players right where many falter: long-term ownership. They're rolling out MADE, a new initiative focused on flipping that burst...

Strategic Move: Chimney Collective Teams with Four Winds

A Partnership Fueled by Legacy and Growth In the world of brick, mortar, and flue, a big play just unfolded. Chimney Collective, flexing its investment muscle, has hitched its wagon to Four Winds Chimney, a company that's carved out quite a niche in New York's chimney scene. We're not talking about a corporate takeover here; this is about putting money where growth and...

Icebox Takes on Buckhead with Diamonds and Discounts

So, Atlanta's Icebox Diamonds & Watches just dropped a news bomb that could shake up anyone with a taste for glitz and a wallet ready to act. This iconic jeweler, swinging its roots from a humble family biz to a global gem, is opening up its vault with an Inventory Reduction Sale starting October 9. And folks, it’s happening right at their Buckhead flagship showroom....

Chianti Classico Showcases 2027 Vintages in Florence

A Grand Reunion of the Black Rooster You're not just sipping wine at a garden party—you're diving into a historic event. Come March 1-2, 2027, Florence will again host the much-anticipated Chianti Classico Collection, uniting over 200 eager producers under the iconic vaults of Stazione Leopolda. This isn't just another stop on the wine circuit; it's a pilgrimage to the...

Mastering Packaging Costs: Beyond the Box Price

Peeling Back the Layers of Packaging Costs Packaging's a bit like an onion—every layer you peel back reveals another cost you didn’t see at first glance. Folks in the know, like Kyle Reger of Jamestown Container Companies, are flipping the script on how we approach packaging expenses. It's not just about snagging the cheapest box on the shelf anymore. There's a whole...

Bill Evans Enhances Gateway's Wealth Management Expertise

Welcome Aboard, Bill Evans Some days the financial world throws a gem your way, something worth more than a rat-race racehorse in a shattered stock rally. Meet Bill Evans, a seasoned professional stepping into the vibrant arena of Gateway Financial Partners. He’s put in 29 years around the investment block, and now he’s parking himself in Glastonbury, Connecticut, set...

Armor Health Strengthens Corrections Care with New Leader

Fresh Blood in Correctional Healthcare Talk about stepping up where it counts! Armor Health is shaking things up, bringing in Jill Bromley as their new Regional Behavioral Health Director. The name might not ring any bells for the average Joe, but in the world of correctional healthcare, it’s like they've just upgraded from a sedan to a sports car. Armor’s game here...

ODL’s Impact Door System Wins 2026 Editors' Pick

Award-Winning Entry: ODL's Latest Triumph In a world where first impressions count, ODL, Inc. sure knows how to leave a mark. Their Impact Rated Fiberglass Entry System with Keystone Frame Technology snagged a notable spot in the 2026 Best of Products Awards by Architect's Newspaper. Let me tell you, in the building biz, accolades like these are no small potatoes. To get...

Boliden's Q3 2026 Results: What's on the Horizon?

Boliden Ready to Reveal Q3 Numbers Mark it down, folks. Thursday, October 29, 2026, is the day when Boliden's big wigs will step up to the plate and lay their cards on the table about the company's performance over the last quarter. If you've got any skin in this mining powerhouse, you'll want a front-row seat—or at least a virtual one if you're dialing in from...